HomeTagsVaccinex

Tag: Vaccinex

Catalent Biologics and Vaccinex Ink Agreement to Jointly Develop Novel Antibody-Drug...

Peter Hofland
Catalent Pharma Solutions and Vaccinex confirmed their agreement earlier today to jointly develop an antibody-drug conjugate (ADC) using Catalent’s proprietary SMARTag® conjugation platform and...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

MADE POSSIBLE BY
MabPlex

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.